Advances in Cancer Immunotherapy™ - Webinars and Online Modules

Online Advances in Cancer Immunotherapy™ Courses

Complete these free, certified, interactive online courses to deepen your understanding of cancer immunotherapy and learn about the most recent FDA approvals in several diseases states and the latest guidelines on how to treat immune-related adverse events. Additional courses address how to overcome practical barriers to implementation, which are critical for helping your staff to help patients obtain reimbursement for immunotherapy. Each free course is eligible for CME, CNE, CPE and/or MOC credits.

Online courses include links to the original trials, the latest FDA approvals, real-world case studies and questions to help deepen understanding and retention. There are also printable charts outlining best practices for treating immune-related adverse effects and links to the Cancer Immunotherapy Guidelines which can support decision-making.

Click here to register for Online ACI Courses

Log in to the free ACI webinars to learn about new treatment approvals and emerging scientific data relating to clinical applications of cancer immunotherapy. Hosted by experts in the field, the webinars provide an opportunity to continue your learning from this ACI program and interact with faculty during a dedicated question-and-answer session.

Upcoming Advances in Cancer Immunotherapy™ Webinars

Advances in Cancer Immunotherapy™️ Webinar: Clinical Updates from SITC 2020
Date: Tuesday, March 20, 2021 at 4:00-5:00 p.m. ET

Join us as we welcome Jason Luke, MD and other leading experts in cancer immunotherapy as they discuss the latest and most exciting clinical updates emerging from The Society for Immunotherapy of Cancer (SITC) 35th Anniversary Annual Meeting & Pre-Conference Programs (SITC 2020). This FREE, CME-, CNE-, CPE- and MOC- certified webinar is a chance for clinical oncologists, registered nurses, nurse practitioners, advanced practice registered nurses, pharmacists, physician assistants, emergency physicians, allied health professionals, other patient care providers, students, and patient advocates, to learn about key clinical implications from select SITC 2020 presentations. This live webinar will also feature a dedicated question and answer session to address your questions about clinical applications of cancer immunotherapy. Don't miss this opportunity to continue learning about the expanding cancer immunotherapy field!

REGISTER NOW

Featured presentations: 

• Interim analysis of Phase 2 results for cemiplimab in patients with metastatic basal cell carcinoma (mBCC) who progressed on or are intolerant to hedgehog inhibitors (HHIs) – Presenter: Karl Lewis, MD
• First-in-human phase I/IIa trial to evaluate the safety and initial clinical activity of DuoBody®-PD-L1×4-1BB (GEN1046) in patients with advanced solid tumorso – Presenter: Ignacio Melero, MD, PhD
• Phase II Trial of Neoadjuvant Nivolumab (Nivo) and Intra-Tumoral (IT) CMP-001 in High-Risk Resectable Melanoma (Neo-C-Nivo): Final Results – Presenter: Diwakar Davar
• Defining tumor resistance to PD-1 pathway blockade: recommendations from the first meeting of the SITC Immunotherapy Resistance Taskforce – Presenter: Hussein Tawbi, MD, PhD

Webinar Faculty:

• Moderator: Jason Luke, MD – University of Pittsburgh Medical Center
• Presenters:
  • Diwakar Davar, MD – University of Pittsburgh Medical Center
  • Karl Lewis, MD – University of Colorado
  • Ignacio Melero, MD, PhD – Fundación para la Investigación Médica Aplicada
  • Hussein Tawbi, MD, PhD – MD Anderson Cancer Center

Webinar Agenda:

• 4-4:05 p.m. ET  Overview: welcome and introductions
• 4:05-4:45 p.m. ET  Presentation and discussion of content from faculty experts
• 4:45-4:55 p.m. ET  Question and answer session
• 4:55-5 p.m. ET  Closing remarks

Continuing Education Credit Information:
Continuing Education Credits are available for physicians, nurses, and pharmacists. For more information regarding accreditation click here.

On-Demand Webinar Recordings and Slides

• Advances in Cancer Immunotherapy™ Webinar: Clinical Updates from ESMO Virtual Congress 2020 (January 7, 2021)
• Advances in Cancer Immunotherapy™ Webinar: Clinical Updates from ASCO20Virtual (September 10, 2020)
• Advances in Cancer Immunotherapy™ Webinar: Clinical Updates from SITC 2019 (February 4, 2020)
• Advances in Cancer Immunotherapy™ Webinar: Clinical Updates from ESMO Congress 2019 (February 28, 2020)
• Advances in Cancer Immunotherapy™ Webinar: Clinical Updates from ESMO Immuno-Oncology Congress 2019 (June 9, 2020)

Please note that the on-demand webinars are not available for continuing education credits.